ConductScience.org, home

193,990 genes from NCBI Gene.

193,990 genes

Most papers first2,301 to 2,320 of 193,990

Show the results as
GeneNCBI GeneProteinsPatentsDrugsTrialsNIH grantsPapers
CCR9

C-C motif chemokine receptor 9

10803

HGNC:1610

174241,9712,788
ITGA3

integrin subunit alpha 3

3675

HGNC:6139

180001,6472,788
CHD7

chromodomain helicase DNA binding protein 7

55636

HGNC:20626

127001,5302,784
CRK

CRK proto-oncogene, adaptor protein

1398

HGNC:2362

128001,8952,784
NUP98

nucleoporin 98 and 96 precursor

4928

HGNC:8068

16001,9552,783
ACAT1

acetyl-CoA acetyltransferase 1

38

HGNC:93

148001,5042,780
MGLL

monoglyceride lipase

11343

HGNC:17038

159131,5252,780
ACTR3

actin related protein 3

10096

HGNC:170

133001,7042,778
ABAT

4-aminobutyrate aminotransferase

18

HGNC:23

1531201,0852,776
ITCH

itchy E3 ubiquitin protein ligase

83737

HGNC:13890

134001,7612,772
DRD3

dopamine receptor D3

1814

HGNC:3024

124489401,6922,771
HTR1B

5-hydroxytryptamine receptor 1B

3351

HGNC:5287

138251841,7092,771
A4GALT

alpha 1,4-galactosyltransferase (P1PK blood group)

53947

HGNC:18149

148001,2662,770
CYP11B1

cytochrome P450 family 11 subfamily B member 1

1584

HGNC:2591

1175428692,770
KLF6

KLF transcription factor 6

1316

HGNC:2235

137001,8882,770
RAPGEF3

Rap guanine nucleotide exchange factor 3

10411

HGNC:16629

126001,9772,768
GLO1

glyoxalase I

2739

HGNC:4323

135008482,767
MXD1

MAX dimerization protein 1

4084

HGNC:6761

145001,7802,767
IGKV1D-27

immunoglobulin kappa variable 1D-27 (pseudogene)

28898

HGNC:5751

00002,2772,763
PRKACA

protein kinase cAMP-activated catalytic subunit alpha

5566

HGNC:9380

173121,8782,763

Request

GET /api/genes/v1

A gene symbol, alias or name, an NCBI Gene, HGNC, Ensembl or UniProt ID, or a drug's name or ChEMBL ID.

No key needed

Code

Show the call in
curl "https://conductscience.org/api/genes/v1?page=116"

Response

The first 2 of this page's 20 results. GET /api/genes/v1?page=116

{
  "data": {
    "total": 193990,
    "results": [
      {
        "id": "10803",
        "title": "CCR9: C-C motif chemokine receptor 9",
        "summary": "NCBI Gene 10803. 1 protein, 74 patents, 2 drugs, 4 trials, 1,971 NIH grants and 2,788 papers.",
        "record": "/library/genes/10803",
        "gene_id": 10803,
        "symbol": "CCR9",
        "name": "C-C motif chemokine receptor 9",
        "hgnc_id": "HGNC:1610",
        "counts": {
          "proteins": 1,
          "patents": 74,
          "drugs": 2,
          "trials": 4,
          "grants": 1971,
          "papers": 2788
        }
      },
      {
        "id": "3675",
        "title": "ITGA3: integrin subunit alpha 3",
        "summary": "NCBI Gene 3675. 1 protein, 80 patents, 0 drugs, 0 trials, 1,647 NIH grants and 2,788 papers.",
        "record": "/library/genes/3675",
        "gene_id": 3675,
        "symbol": "ITGA3",
        "name": "integrin subunit alpha 3",
        "hgnc_id": "HGNC:6139",
        "counts": {
          "proteins": 1,
          "patents": 80,
          "drugs": 0,
          "trials": 0,
          "grants": 1647,
          "papers": 2788
        }
      }
    ],
    "columns": [
      {
        "key": "symbol",
        "label": "Gene",
        "under": "name"
      },
      {
        "key": "id",
        "label": "NCBI Gene",
        "under": "hgnc_id"
      },
      {
        "key": "counts.proteins",
        "label": "Proteins"
      },
      {
        "key": "counts.patents",
        "label": "Patents"
      },
      {
        "key": "counts.drugs",
        "label": "Drugs"
      },
      {
        "key": "counts.trials",
        "label": "Trials"
      },
      {
        "key": "counts.grants",
        "label": "NIH grants"
      },
      {
        "key": "counts.papers",
        "label": "Papers"
      }
    ],
    "order": "Most papers first"
  },
  "release": "gene-search-2026-11-11-0.2.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ChEMBL, through Open Targets",
      "license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC BY-SA 3.0"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "No license stated"
    },
    {
      "source": "EMBL-EBI's patent proteins",
      "license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
      "notice": null,
      "short": "No added restrictions. Attribution expected"
    },
    {
      "source": "GenBank's patent files",
      "license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
      "notice": null,
      "short": "No restrictions from NCBI. Submitters may hold rights"
    },
    {
      "source": "HGNC",
      "license": "CC0: https://www.genenames.org/about/license/",
      "notice": null,
      "short": "CC0"
    },
    {
      "source": "NCBI Gene",
      "license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
      "notice": null,
      "short": "Public domain (US government)"
    },
    {
      "source": "NIH's project files and grant-paper links",
      "license": "Public domain (NIH RePORTER)",
      "notice": null,
      "short": "Public domain"
    },
    {
      "source": "Open Targets",
      "license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC0 1.0"
    },
    {
      "source": "PubMed",
      "license": "NLM's terms",
      "notice": null,
      "short": "NLM's terms"
    },
    {
      "source": "PubTator 3",
      "license": "Public domain",
      "notice": null,
      "short": "Public domain"
    },
    {
      "source": "UniProt",
      "license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
      "notice": null,
      "short": "CC BY 4.0"
    }
  ],
  "next": "/api/genes/v1?page=117",
  "request_id": "0Xxm89ruqcqQgJHj"
}

Ask about these results. The first 10 go in the prompt.

About this data
Holds
193,990 genes
From NCBI Gene. Counted 11 Nov 2026.
Release
11 Nov 2026
gene-search-2026-11-11-0.2.0
Checked
20 of 20 review genes traced to the raw source files, every checked row right
Access
Open
No account. 60 calls a minute from one address.

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Trial comparisons

ClinicalTrials.gov

Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

Opens sequences.conductscience.org

For software

Read Genes from software.

Every answer on this page is also JSON, under /api/genes/v1. No key.

GET https://conductscience.org/api/genes/v1?q=p53

Ask an assistant

  • Which drugs act on PCSK9, and which of their trials posted results?
  • How many patents list the exact protein sequence of TP53?
  • Which genes does evolocumab act on?
  • Which NIH grants have the most papers about APOE?